Skip to main content

Table 1 Sociodemographics and practice experience of sample (N = 50)

From: Formative acceptance of ingestible biosensors to measure adherence to TB medications

Variable

Mean (SD)

Age (in years)

34.3 (7.3)

 

Median (IQR)

Years of experience in managing patients with TB

4 (3, 6)

 

n (%)

Sex

 Male

35 (70%)

 Female

15 (30%)

Occupational status

 General physician/practitioner (internist)

26 (52%)

 Pulmonologist

15 (30%)

 *NTEP officials

7 (14%)

 WHO consultant

1 (2%)

 **RNTCP Senior treatment supervisor

1 (2%)

Current clinical practice location

 Kerala

42 (84%)

 Karnataka

1 (2%)

 Madhya Pradesh

1 (2%)

 Tamil Nadu

2 (4%)

 Telangana

1 (2%)

 Uttar Pradesh

1 (2%)

 Not specified

2 (4%)

Number of patients with TB treated in the past year

 0–10

13 (26%)

 11–50

21 (42%)

 51–100

8 (16%)

 More than 100

8 (16%)

Percentage of TB patients with perceived adherence issues

 Less than 10%

25 (50%)

 10–25%

19 (38%)

 26–50%

4 (8%)

 51–75%

0 (0%)

 76–100%

2 (4%)

Perceived reasons for nonadherence among patients on ATT

 Cost of transport to DOTS clinic

5 (10%)

 Lack of understanding of importance of ATT adherence

38 (76%)

 Stigma of TB

3 (6%)

 Forgetfulness

9 (18%)

 Improvement of symptoms

26 (52%)

 Adverse drug effects

4 (8%)

 Others

2 (4%)

Awareness of adherence monitoring strategies used for ATT

 99DOTS

33 (66%)

 Regular DOTS

35 (70%)

 Health worker’s visit at home

43 (86%)

 Phone call or text message reminders

38 (76%)

 Digital pill

10 (20%)

 Digital pill box

7 (14%)

 Other electronic adherence system

4 (8%)

 Other

1 (2%)

Adherence monitoring strategies previously used with patients

 99DOTS

26 (52%)

 Regular DOTS

29 (58%)

 Health worker’s visit at home

34 (68%)

 Phone call or text message reminders

19 (38%)

 Digital pill

0

 Digital pill box

0

 Other electronic adherence system

2 (4%)

 Other

2 (4%)

Asks patients about ATT adherence during clinical visits

 Yes

39 (78%)

 No

11 (22%)

  1. *NTEP: National Tuberculosis Elimination Program
  2. **RNTCP: Revised National Tuberculosis Control Program